Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
412.2 GBX | +0.41% | -2.48% | -6.49% |
Apr. 23 | Corporate results bound the become the next catalyst for markets | |
Apr. 23 | JPMorgan Resumes Rentokil Initial Coverage with Neutral Rating | MT |
Sales 2024 * | 5.53B 6.9B | Sales 2025 * | 5.8B 7.24B | Capitalization | 10.35B 12.93B |
---|---|---|---|---|---|
Net income 2024 * | 399M 498M | Net income 2025 * | 522M 652M | EV / Sales 2024 * | 2.42 x |
Net Debt 2024 * | 3.01B 3.76B | Net Debt 2025 * | 2.68B 3.35B | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 * |
26.3
x | P/E ratio 2025 * |
20.1
x | Employees | 62,931 |
Yield 2024 * |
2.2% | Yield 2025 * |
2.48% | Free-Float | 98.9% |
Latest transcript on Rentokil Initial plc
1 day | +0.41% | ||
1 week | -2.48% | ||
Current month | -12.61% | ||
1 month | -12.76% | ||
3 months | +2.03% | ||
6 months | -2.09% | ||
Current year | -6.49% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Ransom
CEO | Chief Executive Officer | 60 | 08-04-30 |
Director of Finance/CFO | - | 06-12-31 | |
Brian Webb
COO | Chief Operating Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David J. Frear
BRD | Director/Board Member | 67 | 22-09-30 |
Richard Solomons
CHM | Chairman | 62 | 19-02-28 |
Andrew Ransom
CEO | Chief Executive Officer | 60 | 08-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 5 M€ | +8.63% | ||
0.84% | 11 M€ | +0.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 412.2 | +0.41% | 14,654,690 |
24-04-25 | 410.5 | -1.86% | 14,125,060 |
24-04-24 | 418.3 | -1.58% | 6,167,842 |
24-04-23 | 425 | -0.35% | 10,385,190 |
24-04-22 | 426.5 | +0.90% | 19,314,430 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RTO Stock